Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

CD40 Stimulation of Human Peripheral B Lymphocytes: Distinct Response from Naive and Memory Cells

Jessie F. Fecteau and Sonia Néron
J Immunol November 1, 2003, 171 (9) 4621-4629; DOI: https://doi.org/10.4049/jimmunol.171.9.4621
Jessie F. Fecteau
Héma-Québec, Recherche et Développement, Sainte-Foy, Québec, Canada; and Département de Biochimie et Microbiologie, Université Laval, Laval, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonia Néron
Héma-Québec, Recherche et Développement, Sainte-Foy, Québec, Canada; and Département de Biochimie et Microbiologie, Université Laval, Laval, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

During secondary immune response, memory B lymphocytes proliferate and differentiate into Ig-secreting cells. In mice, the binding of CD40 by CD154 clearly enhances the activation and differentiation of memory B lymphocytes. In humans, the role of CD40-CD154 in the stimulation of memory B lymphocytes is not as obvious since in vitro studies reported positive and negative effects on their proliferation and differentiation in Ig-secreting cells. In this study, we examine the response of peripheral memory and naive cells in relation to the duration of CD40-CD154 interaction. We measured the proliferation and differentiation of both subsets stimulated with CD154 and IL-4 for short- (4–5 days) and long-term (>7 days) periods. Following short-term stimulation, memory B lymphocytes did not expand but represented the only subset differentiating into IgG- and IgM-secreting cells. A longer stimulation of this population led to cell death, while promoting naive B lymphocyte proliferation, expansion, and differentiation into IgM- or IgG-secreting cells. This prolonged CD40 stimulation also triggered naive B lymphocytes to switch to IgG and to express CD27 even in absence of somatic hypermutation, suggesting that these latter events could be independent. This study suggests that naive and memory B lymphocytes have distinct requirements to engage an immune response, reflecting their different roles in humoral immunity.

Human peripheral blood B lymphocytes can be divided in two distinct populations: naive B lymphocytes (60%) and memory B lymphocytes (40%) (1). Previous studies have used membrane IgD expression to distinguish naive and memory B lymphocytes, considering that only IgD− cells were memory B lymphocytes (2, 3). The recent finding that the expression of CD27 is restricted to memory B lymphocytes has facilitated distinction between these two populations (1, 4, 5). CD27, belonging to the TNFR family (6), is a surface Ag expressed on a T lymphocyte subset (7) and on B lymphocytes carrying somatic hypermutation in their Ig V region genes, known as memory B lymphocytes (1). Both subsets can be further separated according to the expression of IgA, IgD, IgG, and IgM. All naive B lymphocytes are IgD+IgM+CD27−, while memory B lymphocytes can be IgD+IgM+CD27+, IgD−IgM+CD27+, or IgG+/IgA+CD27+, representing, respectively, 15, 10, and 15% of circulating B lymphocytes (1). Following antigenic challenge, responding B lymphocytes proliferate and form germinal centers (8, 9) while interacting with activated T lymphocytes by direct cell-cell contact and soluble factors (10, 11). This response requires the stimulation of CD40 expressed on B lymphocytes by its ligand, CD154, expressed on activated T lymphocytes (12). The binding of CD154 induces CD40 trimerization, triggering a signaling cascade leading to maturational events (13).

The importance of CD40 stimulation has been demonstrated in patients suffering from X-linked hyper- IgM syndrome, in which CD154 mutations block CD40-CD154 interaction (14, 15). In these cases, B lymphocyte activation and Ig production are impaired, resulting in a nonfunctional immune response to T-dependent Ags (14). Studies using CD40/CD154 knockout mice pointed out the importance of CD40 signaling in B lymphocyte activation, proliferation, and differentiation (reviewed in Refs. 12 and 15). The failure of CD40-CD154 interaction shows that it is essential for isotype switching, somatic hypermutation, generation of memory B lymphocytes, and Ig production (14, 16). However, most of these studies were focusing on naive B lymphocytes and primary immune response. The involvement of CD40-CD154 interaction is more difficult to establish for memory B lymphocytes in relation to secondary immune response, since the disruption of CD40/CD154 blocks the generation of these cells in in vivo models (14, 16). Nevertheless, immunohistochemical studies revealed that CD154-expressing T lymphocytes are found in close proximity to Ag-specific B lymphocytes after secondary immunization (17). In addition, the injection of neutralizing anti-CD154 Abs in mice inhibits the secondary humoral response to T-dependent Ags (15, 18), supporting that CD40 signaling is essential in memory B lymphocyte response.

In humans, the study of B lymphocyte activation via CD40 is limited to in vitro models. Until now, the impact of CD40 stimulation on B lymphocytes from peripheral blood or tonsils has been studied using different tools to stimulate CD40: cells transfected with CD154, anti-CD40 Abs (19, 20, 21, 22), or soluble CD154 (23) in the presence of IL-4 (24, 25). A brief overview of the previous works suggested different effects of CD40 stimulation in memory and naive B lymphocyte responses. Some studies reported that the proliferation of memory and naive B lymphocytes was equivalent following short-term (21, 22) or long-term CD40 stimulation (26). In contrast, others have shown the predominance of IgD+ naive B lymphocyte proliferation over IgD− memory cells (19, 20, 27). Nevertheless, Ig secretion was restricted to differentiated memory B lymphocytes (19, 21, 22, 23, 27). Even though in vivo studies with mouse models demonstrated the requirement of CD40 stimulation for memory B lymphocyte response, the outcome of this population remains unclear in humans.

To help clarify this matter, peripheral human B lymphocytes were separated into CD27+ memory and CD27− naive B lymphocyte populations. Both subsets were stimulated in vitro through CD40 with a cell line expressing CD154 in the presence of IL-4. Proliferation and Ig secretion were monitored during short (4–5 days)- and long-term stimulations (>7 days). We observed a distinct response from naive and memory cells related to the duration of CD40 stimulation. Memory B lymphocytes differentiated rapidly to produce IgG and IgM with no expansion, followed by cell death. In contrast, naive CD27− cells expanded rapidly and differentiated to secrete Ig only after a longer stimulation. This population also performed isotype switching and acquired CD27 expression in the absence of significant somatic hypermutation, suggesting that these events could be independent in the generation of memory B lymphocytes. These observations are in accordance with the role of both subsets in primary and secondary immune responses.

Materials and Methods

Isolation of human peripheral B lymphocytes

Blood samples were collected from healthy individuals after informed consent in heparinized tubes (Vacutainer; BD Labware, Franklin Lakes, NJ), pooled, and diluted in 1 vol of PBS (10 mM potassium/sodium phosphate buffer with 136 mM NaCl (pH 7.4), Dulbecco’s PBS; Life Technologies, Grand Island, NY). PBMC were prepared by density centrifugation over Ficoll-Paque (Amersham Pharmacia Biotech, Baie D’Urfé, Canada). RBC were removed by lysis with 0.83% (w/v) NH4Cl and platelets by a second centrifugation over Ficoll-Paque diluted 1/2 with PBS. B lymphocytes were purified by negative selection using the StemSep CD19 mixture according to the manufacturer’s instructions (StemCell Technologies, Vancouver, Canada). Purified human B lymphocytes were >90% CD19+ as determined by flow cytometry analysis. CD27+ and CD27− B cells were separated by cell sorting, using an Epics Coulter (Beckman Coulter, Burlington, Canada), under sterile conditions. Both purified populations were >90% pure, as determined by flow cytometry.

Culture of human B lymphocytes

Purified B lymphocytes were seeded at 3.75 × 105 cells/ml in Primaria plates (BD Labware) in the presence of 0.5 × 105 cells/cm2 gamma-irradiated with 75 Gy (7500 rad) L4.5 expressing CD154 (28). The specificity of the response induced by CD154 expressed on L929 (L4.5 cell line) has been previously confirmed using mock-transfected L929 cells and cytokines as described elsewhere (28). Human B lymphocytes were cultured in IMDM supplemented with 10% heat-inactivated ultra-low IgG FBS (Life Technologies), 5 μg/ml bovine insulin, 5 μg/ml bovine transferrin, antibiotics, and 100 U/ml IL-4 (R&D Systems, Minneapolis, MN) or 25 U/ml IL-10 or 50 U/ml IL-2 (PeproTech, Rocky Hill, NJ) as indicated. Preincubation with 0.01% Staphylococcus aureus (SAC3 Cowan strain I, protein A insoluble; Sigma-Aldrich, Oakville, Ontario, Canada) was used as indicated. Cultures were fed by replacing half of the culture medium every 2–3 days, while irradiated L4.5 cells were renewed every 4–5 days. Cell counts and viability were evaluated in triplicates by trypan blue exclusion using a hemacytometer. B lymphocytes were cultured for short-term (< 10 days) or long-term periods (> 3 wk) as indicated. During these periods, cells were always >96% CD19+.

Quantification of IgG and IgM secretion

IgG and IgM concentrations were determined in a standard ELISA using 96-well plates and plastic-adsorbed goat affinity-purified Abs specific to human γ- and μ-chains. The bound Abs were revealed with peroxidase-conjugated goat polyvalent anti-human Ig Abs. All Abs were obtained from The Jackson Laboratory (Mississauga, Ontario, Canada). Tetramethylbenzidine (ScyTek Laboratories, Logan, UT) was used as substrate and OD were measured at 450/630 nm.

Determination of the proportion of Ig-secreting cells

The proportion of cells secreting IgA, IgG, or IgM was determined by a standard ELISPOT assay (29) using the same Ab sandwich described for the ELISA. Cells were washed, seeded in 96-well flat-bottom plates at 100–20,000 cells/ml, and incubated in culture medium for 6 h at 37°C in a 10% CO2 incubator. Spots were revealed by addition of polyvalent alkaline phosphatase-conjugated goat anti-human specific for κ-, λ-, α-, γ-, and μ-chains. A solution of 1.5 M 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt prepared in 2-amino-2-methyl-1-propanol was used as substrate (Sigma-Aldrich). The spots were counted under the microscope at ×100 magnification.

Flow cytometry analysis

Allophycocyanin-, PerCP-cyanin 5.5-, or FITC-conjugated anti-CD19, PE-conjugated anti-CD27, FITC-conjugated anti-IgG, and allophycocyanin-, PerCP-cyanin 5.5-, PE-, and FITC-conjugated isotype controls were used in double, triple, or quadruple staining procedures. All Abs were IgG1 mouse mAbs obtained from BD PharMingen (Oakville, Ontario, Canada). All stainings were done with 1 μg of each Ab for 1 × 106 cells at 4°C. Cells were fixed with 2% paraformaldehyde. In all analyses, over 95% of cells was double negative with markers set according to isotype-matched negative control staining. The regions containing dead cells were determined using 7-amino-actinomycin D staining, following the manufacturer’s instructions (BD PharMingen). Analyses were done by gating 5,000–10,000 cells with a FACSCalibur flow cytometer and the CellQuest software (BD Biosciences, Mountain View, CA).

Cell proliferation assays

Highly purified CD19+, CD27+, and CD27− B lymphocytes were seeded at 7.5 × 104/ml in triplicates in flat-bottom 96-well plates in the presence of 2.5 × 104 irradiated L4.5 cells. B lymphocytes were cultured as previously described. Cellular proliferation was monitored using 5-bromo-2′-deoxyuridine (BrdU) incorporation and detection by colorimetric ELISA according to the manufacturer’s instructions (Roche Molecular Biochemicals, Indianapolis, IN).

RT-PCR amplification of activation-induced cytidine deaminase (AID) mRNA

Total RNA from L4.5, Ramos cell line (CRL-1596; American Type Culture Collection, Manassas, VA) (30), human B lymphocytes, and CD19+ and CD27− B lymphocytes cultured for 28 days with L4.5 and IL-4 was isolated using TRIzol reagent (Invitrogen, Burlington, Ontario, Canada). RT-PCR amplification of AID using primer 5′ (5′-GAG GCA AGA AGA CAC TCT GG-3′) and 3′ (5′-CAA AAG GAT GCG CCG AAG CTG TCT GGA G-3′) generated a unique 569-bp fragment. RT-PCR was performed starting from 150 ng total RNA, using the Titan One Tube RT-PCR System according to the manufacturer’s instructions (Roche Diagnostics Canada, Laval, Quebec, Canada). Following a 30-min reverse transcription at 50°C, a PCR composed of 33 cycles of 45 s at 94°C, 45 s at 57°C, and 45 s at 72°C was applied. Cycling was followed by a final elongation period of 10 min at 72°C. No AID mRNA was detected in L4.5 cells. β-Actin amplification was used as internal control in RT-PCR, starting from 150 ng total RNA. The primers used in 5′ (5′-GTG GGG CGC CCC AGG CAC CA-3′) and 3′ (5′-CTC CTT AAT GTC ACG CAC GAT TTC-3′) generated a single 540-bp fragment. Negative control without RNA confirmed theabsence of cross-contamination.

PCR amplification of human IgG1 VH regions

Total RNA from human B lymphocytes and CD19+ and CD27− B lymphocytes cultured for 28 days with L4.5 and IL-4 was prepared and 750 ng was used for RT-PCR as described above. For amplification, a nondegenerated primer (D075: 5′-TGG TGG TAC CCA CTG AAC ACA GAG GAC TCA-3′) was used to hybridize to the cDNA 5′ untranslated region of all human VH family members, paired with a primer specific for the CH2 region of human IgG1 (hCγ1: 5′-GCA TGT GTG AGA CTA GTC ACA AGA TTT GGG-3′). Following a 30-min reverse transcription at 50°C, a touchdown PCR cycling protocol was done as follow: 35 cycles of 30 s at 94°C, 60 s at 65°C (1°C decrease per cycle for the first 10 cycles, and the last 25 cycles at 55°C), and 60 s at 72°C. Cycling was followed by a final elongation period of 10 min at 72°C. Negative controls without RNA or with RNA isolated from the IgM-producing Ramos cell line confirmed the absence of cross-contamination.

Subcloning and sequencing of human IgG1 VH PCR products

Human IgG1 VH amplicons were resolved on 1% agarose gel electrophoresis and the band corresponding to amplicon size ranging between 730 and 830 bp was excised. DNA was purified using the QIAquick Gel Extraction kit (Qiagen, Mississauga, Ontario, Canada) and subcloned into the pCRII-TOPO vector (TOPO TA Cloning kit; Invitrogen) according to the manufacturer’s instructions. Plasmid DNA was isolated and purified by standard procedures (31) and inserts were sequenced by automated fluorescent DNA sequencing (ABI 373; PerkinElmer Applied Biosystems, Foster City, CA). From two donors, a total of 18 clones from cultured CD19+ and 16 from sorted CD27− B lymphocytes were characterized. To establish the error rate of Taq DNA polymerase mix (Titan One Tube RT-PCR System), the CH1 and CH2 domains of the IgG constant region from 10 different clones were compared with sequences from GenBank. From this analysis, the Taq DNA polymerase error frequency was estimated to be 0.34%, which corresponds to 1 bp over 294.

Mutation analysis of IgG1 VH genes

Mutation analysis of the VH clones was done using the ImMunoGeneTics database available on the internet (the international ImMunoGeneTics database http://imgt.cines.fr:8104 (32, 33, 34)). The number of mutations was determined after the alignment of each sequenced amplicon with the germline gene presenting the highest homology from framework 1 to framework 3 regions, for a total of 312 bp. Mutation proportions were established from the ratio mutated bp:total number of bp.

Results

High level of IgM-secreting cells are generated following CD40 stimulation

In vitro proliferation and differentiation of human B lymphocytes can be achieved by stimulation with CD154 and IL-4 (25). As reported previously, in this system the cell growth is characterized by three phases (35): the initiation period (< 7 days) followed by an exponential growth during 1 or 2 wk and a plateau phase where proliferation is stopped. We have evaluated the viability and cellular expansion of human peripheral blood B lymphocytes when stimulated through CD40 in the presence of IL-4 for 37 days (Fig. 1⇓a). We observed that viability was stable (91 ± 5%) as long as the cellular expansion was high, but decreased rapidly from days 28 to 37 (81–28%) after expansion has reached its maximum (1000-fold) on day 23.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Human B lymphocytes proliferate and secrete mainly IgM following CD40 stimulation. Purified human B lymphocytes were cultured with irradiated L4.5 cells in complete medium containing 100 U/ml IL-4 for 37 days. Cell numbers and viability were evaluated in triplicates by trypan blue exclusion. Expansion factors and viability (a) were evaluated using viable and dead cell numbers at indicated times. Error bars can be smaller than symbols. In parallel, the proportion of cells secreting IgA, IgG, and IgM (b) was determined using ELISPOT assays. These results are representative of experiments done with cells from three donors.

In parallel, the proportion of IgA-, IgG-, and IgM-secreting cells was evaluated on days 1, 6, 14, 22, 28, and 36 using ELISPOT assays (Fig. 1⇑b). No Ig-secreting cells were detected on days 1 and 6. After 14 days, IgG- and IgM-secreting cells represented 2 and 8% of the total cells, respectively. The proportion of IgA-, IgG-, and IgM-secreting cells increased more rapidly after day 22, whereas expansion was maximum, reaching 7, 16, and 28% of the total cell number, respectively. Until day 28, IgM-secreting cells represented >70% of total Ig-secreting cells. IgA- and IgG-secreting cells increased more rapidly after 28 days, representing ∼50% of total secreting cells. These results could be interpreted in three ways: long-term CD40 stimulation allows the expansion and differentiation of both memory and naive cells with or without isotype switching or no expansion of memory cells but expansion, differentiation, and isotype switching by naive cells.

CD27+ B lymphocyte proportion decreases rapidly following CD40 stimulation

In peripheral blood, IgA- and IgG-expressing cells are CD27+ memory B lymphocytes, whereas IgM-expressing cells are mainly (75%) CD27− naive B lymphocytes (4, 36). The previous observations showing that the balance between IgM- and isotype-switched Ig-secreting cells changed over time (Fig. 1⇑) led us to analyze the progression of CD27+ memory and CD27− naive B lymphocyte populations in the presence of CD154 and IL-4. The expression of CD27 on CD19+ B lymphocytes was then evaluated by flow cytometry during a long-term stimulation (28 days; Fig. 2⇓). We observed that the proportion of CD27+ memory cells rapidly decreased from 23% on day 0 to 5% on days 6 and 9. Unexpectedly, a CD27+ population (25%) reappeared on day 14. This population kept increasing, reaching 46% on day 23 and remained around 40% until day 28. However, the expression level of CD27 on this emerging CD19+CD27+ population was lower (mean fluorescence intensity (MFI) = 26) than the expression level on peripheral B lymphocytes on day 0 (MFI = 80). These results indicate that memory cells could be able to modulate CD27 expression and to expand or that only CD27− naive B lymphocytes could be able to expand and acquire CD27 expression following long-term stimulation with CD154 and IL-4.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

The proportion of CD27+ memory B lymphocytes decreases rapidly following CD40 stimulation. Purified human B lymphocytes were cultured, as described in Fig. 1⇑, for 28 days (d). The expression of CD19 and CD27 was evaluated by flow cytometry using direct double staining with PE-conjugated anti-CD27 and allophycocyanin-conjugated anti-CD19 Abs. These results are representative of experiments done with cells from three donors.

Proliferation of CD27+ memory B lymphocytes is engaged following CD40 stimulation, but does not lead to expansion

The decrease of CD27+ memory B lymphocytes (Fig. 2⇑) could be caused by a modulation of CD27 expression or a loss of this population. To discriminate between these possibilities, the expansion of sorted CD27+ (92%) and CD27− (97%) B lymphocytes was evaluated in parallel with total CD19+ cells (93%) as control by viable cell counts (Fig. 3⇓, a and b). The total cell number of all populations was stable during the first 5 days, with a viability of 92 ± 1%. On day 9, total CD19+ and CD27− naive cells started to expand at a similar rate with a high viability level (94 ± 2%). In contrast, the number of CD27+ cells decreased by almost 10-fold after 9 days and mortality was increased to 52%. These results suggest that CD27+ memory B lymphocytes are lost following CD40 stimulation as a result of cell death.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

CD27+ memory B lymphocytes do not expand following CD40 stimulation. Total CD19+ and sorted CD27+ memory and CD27− naive B lymphocytes were cultured, as described in Fig. 1⇑, for 22 (b) or 7 (c) days. The expression of CD19 and CD27 (a) was evaluated on total CD19+ and on sorted CD27+ and CD27− B lymphocytes by flow cytometry using direct double staining with PE-conjugated anti-CD27 and FITC-conjugated anti-CD19 Abs. These profiles are representative of the two samples used in b and c. Expansion factors (b) were determined as described in Fig. 1⇑ for total CD19+, CD27+, and CD27− B lymphocytes. Proliferation (c) was measured by BrdU incorporation, as described in Materials and Methods, on days 1, 4, and 7 for all subsets. Error bars can be smaller than symbols. These results are representative of experiments done with cells from three donors.

To further characterize the outcome of these B lymphocyte populations during the initiation phase, their proliferation was evaluated using BrdU incorporation after 1, 4, and 7 days of CD40 stimulation (Fig. 3⇑c). As observed above (Fig. 3⇑b), total CD19+, CD27− naïve, and CD27+ memory B lymphocytes showed similar proliferation levels during the first 4 days. After 7 days, the proliferation rate was increased in total and naive cells, while CD27+ cell proliferation remained as low as that of day 4. Then, the dramatic decrease observed in the CD27+ population can be attributed to a low proliferation combined with an increased cell death and not to the modulation of CD27 expression. These results suggest that CD27− naive B lymphocytes were advantaged over CD27+ memory B lymphocytes and represented the only subset able to expand in these culture conditions.

Memory B lymphocytes differentiate into Ig-secreting cells earlier than naive cells after CD40 stimulation

To evaluate the capacity of total CD19+, CD27−, and CD27+ B lymphocytes to differentiate into Ig-secreting cells following CD40 stimulation, we used standard ELISA. IgG and IgM secretion was monitored after short (5 days)- and long-term (14 and 22 days) stimulation of the sorted populations (Table I⇓). After 5 days, only CD27+ memory B lymphocytes differentiated into IgG- and IgM-secreting cells. After 14 days, while sorted CD27+ cells were all dead, CD27− cells started to differentiate into IgM- and IgG-secreting cells. On day 22, as indicated by IgG and IgM secretion, the differentiation level was indistinguishable in sorted CD27− and total CD19+ B lymphocytes. Consequently, CD27− cells were the only subset able to respond to the long-term CD40 stimulation by expansion and differentiation. In addition, these results show that memory B lymphocytes differentiate more rapidly than naive cells following CD40 stimulation. Also, it suggests the capacity of naive cells to perform isotype switching.

View this table:
  • View inline
  • View popup
Table I.

Memory B lymphocytes differentiate more rapidly than naive cells after CD40 stimulation

Naive B lymphocytes can acquire CD27 expression following CD40 stimulation

Based on the results presented in Fig. 3⇑ and Table I⇑, we concluded that CD27− naive B lymphocytes were the only cell subset responding to prolonged CD40 stimulation. Since CD27+ cells emerged in high proportion (>40%) following a sustained stimulation (>23 days; Fig. 2⇑), we assessed whether CD27 expression could be induced on naive B lymphocytes. Total CD19+ and sorted CD27− B lymphocytes were stimulated with CD154 and IL-4, and the expression of CD27 was evaluated by flow cytometry (Fig. 4⇓). Total CD19+ and CD27− B lymphocytes showed a similar progression of CD27 expression on days 9, 19, and 28 (Fig. 4⇓). On day 28, populations issued from total CD19+ and naive CD27− B lymphocytes showed 31 and 37% CD19+CD27+ cells, respectively. The MFI was similar in both populations, but lower in emerging CD27+ B lymphocytes (MFI = 29) than in the initial peripheral populations (MFI = 61). In human tonsils, low expression of CD27 has been observed on a B cell subset (CD20+CD38low/−) in germinal center (37). We have also observed that these newly formed CD27+ B lymphocytes expressed a normal level of CD19 and a low level of CD38 (data not shown). In addition, most (>98%) of the cells were CD138− (data not shown). These results indicate that CD27 expression can be induced on naive B lymphocytes, confirming that the newly formed CD27+ population can emerge from CD27−cells following long-term CD40 stimulation.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

CD27+ B lymphocytes are generated from naive CD27− B lymphocytes following long-term CD40 stimulation. Total CD19+ B lymphocytes and sorted CD27− naive B lymphocytes were cultured, as described in Fig. 1⇑, for 28 days. The expression of CD19 and CD27 was evaluated on days 0, 9, 19, and 28 by flow cytometry, as described in Figs. 2⇑ and 3⇑. These results are representative of experiments done with cells from three donors.

Long-term CD40 stimulation of naive B lymphocytes can induce isotype switching

Following long-term stimulation, we observed a high level of IgG secretion from remaining naive B lymphocytes (Table I⇑). To verify the occurrence of isotype switching, the proportion of IgG+ cells was monitored in total CD19+ and sorted CD27− populations following CD40 stimulation (Fig. 5⇓). As observed for CD27+ cells (Fig. 4⇑), the IgG+ population decreased rapidly within the total CD19+ population and reappeared gradually during the culture. Total CD19+ and naive CD27− B lymphocytes showed a similar progression of IgG+ cells, reaching 7 and 9% on day 28, respectively, indicating that naive B lymphocytes have been able to switch.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

IgG+ B lymphocytes are generated from naive CD27− lymphocytes following long-term CD40 stimulation. Total CD19+ B lymphocytes and sorted CD27− naive B lymphocytes were cultured for 28 days as described in Fig. 1⇑. The expression of CD19 and IgG was evaluated on days 0, 9, 19, and 28 by flow cytometry using direct double staining with FITC-conjugated anti-IgG and allophycocyanin-conjugated anti-CD19 Abs. These results are representative of experiments done with cells from three donors.

To further investigate, the expression of AID mRNA, essential for isotype switching and somatic hypermutation (38), was monitored in comparison to β-actin mRNA in resting and CD40-activated B lymphocytes (Fig. 6⇓). Amplification conditions allowed the detection of AID mRNA in the Ramos cell line, which expresses low levels of AID (30). In comparison to the low level observed in Ramos, the expression of AID was high and similarly induced in both sorted naive and total CD19+ cells. This further supports that naive B lymphocytes can carry out isotype switching.

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

Expression of AID is induced in total CD19+ cells and sorted CD27− cells after long-term CD40 stimulation. Total CD19+ and sorted CD27− B lymphocytes were cultured for 28 days as described in Fig. 1⇑. In parallel with β-actin mRNA, AID mRNA was amplified by RT-PCR and analyzed on a 1% agarose gel electrophoresis for both populations on day 28 as described in Materials and Methods (lanes 4 and 5). A 100-bp DNA ladder was used as marker (lane 1). Ramos cell line mRNA (lane 2) and human resting B lymphocytes mRNA (lane 3) were used as control. These results are representative of experiments done with cells from two donors.

In addition, triple staining was used to monitor CD27 and IgG expression within the CD27− population (Fig. 7⇓). The first IgG+ cells detected were not expressing CD27. This IgG+CD27− population represented 77 and 68% of all IgG+ cells on days 9 and 19, respectively. In contrast, on day 28, the majority (69%) of the IgG+ population was expressing CD27. Similar results were obtained with total CD19+ B lymphocytes following long-term stimulation (data not shown). This last observation indicates that isotype switching and CD27 expression in naive B lymphocytes can occur independently on different populations or that IgG switching occurs before CD27 expression following long-term stimulation.

FIGURE 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 7.

IgG+ and CD27+ B lymphocytes are two distinct populations until 28 days of CD40 stimulation. CD27− naive B lymphocytes were cultured for 28 days as described in Fig. 1⇑. The expression of CD27 and IgG was evaluated on days 0, 9, 19, and 28 by flow cytometry using direct double staining with PE-conjugated anti-CD27 and FITC-conjugated anti-IgG Abs. These results are representative of experiments done with cells from three donors.

Emerging IgG+ B lymphocytes are characterized by the absence of somatic mutations in their VH genes

To rule out the possibility that residual CD27+ memory B lymphocytes could be responsible for the emerging CD27+ population, the presence of somatic mutations in IgG1 VH genes was evaluated for total CD19+ and sorted CD27− naive B lymphocytes after a 28-day CD40 stimulation (Table II⇓). All sequences amplified were part of the larger VH family, VH3. The number of mutations per clone (312 nt) ranged from 0 to 3 (<0.96%) and 0 to 5 (<1.6%) in total CD19+ and naive CD27− B lymphocytes, respectively. Considering a Taq DNA polymerase error frequency of 0.34%, the number of unmutated clones was 89 and 69% for total CD19+ and CD27− B lymphocytes, respectively. The remaining mutated clones showed 5 or less mutations, which can be expected for this in vitro stimulation (39, 40) but is not significant when compared with 13–34 mutations obtained from peripheral memory B lymphocytes. Despite the fact that AID mRNA was expressed in both populations (Fig. 6⇑), it was not sufficient to achieve somatic hypermutation. Overall, the low frequency of somatic mutations in IgG+ cells confirmed the disappearance of memory B lymphocytes and the switching to IgG by naive cells following long-term CD40 stimulation. It also suggests that CD27 expression can be acquired without somatic hypermutation and that the rapid loss of the CD27+ population corresponds to the loss of memory B lymphocytes.

View this table:
  • View inline
  • View popup
Table II.

Few somatic mutations are detected in IgG V region genes from IgG+ cells emerging from total CD19+ and CD27− naive B lymphocytes after 28 days of CD40 stimulation

Naive B lymphocytes could be advantaged over memory cells by L4.5

In vivo, CD40 stimulation of memory and naive B lymphocytes occurs in a complex environment involving Ag, cytokines, and accessory cells. In vitro, simple signals such as IL-4 and CD154 (20, 24, 25) and more recently IL-10 and CD154 (41) have been reported to induce proliferation in tonsillar and splenic naive and memory B lymphocytes. To verify that CD154 and IL-4 were not limiting for memory B lymphocyte response, we used additional signals, including IL-2, IL-10, and SAC, for 3–5 days. Based on the relationship observed between the rapid disappearance of CD27+ cells and the absence of somatically mutated cells (Fig. 4⇑ and Table II⇑), we used as an indicator the expression of CD27 and IgG to follow memory cells (Table III⇓). SAC and IL-2, known to activate memory B lymphocytes (42), allowed their proliferation and maintenance. Similar results were obtained with SAC and IL-4 stimulation, suggesting that IL-4 was not limiting for memory cell response. However, the addition of L4.5 and IL-10 to SAC and IL-2, as well as L4.5 and IL-10 signals did not allow the maintenance of CD27+ and IgG+ cells. These results suggest that stimulation through the B cell receptor (SAC) without L4.5 activated significantly memory B lymphocytes, while L4.5 addition to these signals seemed to favor naive cell expansion. This advantage of naive cells over memory cells could result from the nature of the CD154 signal provided by the L4.5 cell line.

View this table:
  • View inline
  • View popup
Table III.

Naive B lymphocytes could be advantaged over memory cells by L4.5

Discussion

Immune responses to T-dependent Ags are distinct whether or not it is the first encounter with this Ag. During the primary responses, naive B lymphocytes proliferate, differentiate into Ig-secreting cells, and form in parallel a pool of memory B lymphocytes. These memory B lymphocytes are then responsible for the secondary immune responses in which memory cells proliferate and differentiate to produce Ig of higher affinity. Considering the roles of naive and memory B lymphocytes within humoral response kinetics, we could expect that these populations have distinct activation requirements (43, 44). We showed here that naive and memory B lymphocytes isolated from peripheral blood did not respond in the same manner to the same CD154 stimulation. In addition, the short- and long-term periods used to stimulate both populations seemed to amplify these differences. In fact, memory B lymphocytes did not expand, but rapidly differentiated to secrete Ig and started to die (Fig. 3⇑ and Table I⇑), while naive B lymphocytes proliferated exponentially, then differentiated to secrete IgM and IgG and started to express CD27 (Figs. 4⇑, 5⇑, and 7⇑ and Table I⇑). Overall, short-term stimulations favored the differentiation of memory B lymphocytes, whereas long-term stimulations favored naive B lymphocyte expansion and differentiation.

Previous studies using peripheral or tonsillar B lymphocytes reported contrasting behavior of naive and memory cells following CD40 stimulation. In this study, we showed that these discrepancies could be related to the duration of the CD154 signal. Interestingly, the studies showing that memory B lymphocyte proliferation was equivalent to naive cells (21, 22) used a 3-day CD40 stimulation and those reporting a lower proliferation for memory cells than naive cells (19, 27) used a 5- to 7-day stimulation. Our results confirm both of these findings and underline the long-term predominance of naive cells. Until now, Ig secretion has been restricted to differentiated memory B lymphocytes (19, 21, 22, 23, 27), but the duration of CD40 stimulation in each case has never exceeded 14 days. This CD40 stimulation period was probably too short to allow Ig secretion from differentiated naive cells as we report here.

Only a few studies evaluated the response of naive and memory B lymphocytes to long-term CD40 stimulation. Their results demonstrated the expansion of memory cells in vitro, but were obtained from tonsillar B cells (20, 26). Contrary to resting B lymphocytes in blood, tonsillar populations potentially contain activated cells (19) that could be responsible in part for the discrepancy between these results and ours. Overall, all of these studies and ours indicate that naive and memory B lymphocyte response to CD40 stimulation is composed of sequential events that are closely related to the duration of CD40 stimulation.

In vivo, CD40-CD154 interaction is involved in the early immune response of naive B lymphocytes, leading to the generation of memory cells in germinal centers (45). In vitro, CD154 and IL-4 signals stimulated naive B lymphocytes to secrete unmutated IgM and IgG and triggered the expression of AID, CD27, and CD38 but not CD138. These emerging cells were not fully differentiated plasma cells nor memory cells. Our in vitro model seems to allow the accumulation of intermediates that could be temporarily present in germinal centers following CD40 stimulation. The absence of a more complex environment could be responsible for this pause in the differentiation of naive B lymphocytes from the periphery. Interestingly, the generation of these intermediates suggests that isotype switching could occur before or independently of CD27 expression (Fig. 7⇑) and that CD27 expression can be acquired in the absence of somatic hypermutation (Table II⇑). In vivo, CD27+ B lymphocytes showing low somatic mutations can be found in patients suffering from common variable immunodeficiency (46) and persistent polyclonal B cell lymphocytosis (47). In normal germinal centers, the sequence in which CD27 expression, isotype switching, and somatic hypermutation occurs during memory B lymphocyte generation is unknown (48). Although isotype switching has already been described in CD40-stimulated naive B lymphocytes (39, 49, 50), our observations are new indications concerning the independence and the sequence of these events.

Following CD154 and IL-4 stimulation, we showed a distinct response from peripheral naive and memory B lymphocytes. Our results also suggest that even when positive signals for memory B lymphocytes (SAC, IL-2, and IL-10) are added to L4.5 (Table III⇑), naive cells seem advantaged. Such predominance of naive B lymphocytes could be explained by competition mechanisms, resulting from the fact that both populations are receiving the same signals at the same time. Since both resting populations expressed the same level of CD40 (data not shown), the advantage of naive B lymphocytes could also depend on the cell line used, which expresses a heterogeneous level of CD154 (51). We believe that the level of CD154 expression could play a role in the response of naive and memory B lymphocytes, as both subsets seem to require help from naive and memory T cells, respectively (52, 53, 54, 55). Since the level of CD154 expression on memory T lymphocytes is variable upon activation (56, 57), the intensity of the CD154 signal required to enhance memory B lymphocyte expansion remains unclear. We are currently investigating the effect of intensity variation in CD40-CD154 interaction on naive and memory B lymphocyte responses.

Acknowledgments

We thank Annie Roy for her skillful help in flow cytometry and cell culture, Jean-François Leblanc for PCR VH primer design, and Marguerite Massinga-Loembé for her assistance in cloning and sequence analysis. We also thank Claudia Racine for cell culture and Dr. Maryse St-Louis for her careful reading of this manuscript. Finally, we are grateful to Dr. André Darveau for his very helpful suggestions and discussions during the course of this work and for his comments on this manuscript.

Footnotes

  • ↵1 This work was supported by Héma-Québec. J.F.F. was supported by a Ph.D. Fellowship from Le Fonds Québécois de la Recherche sur la Nature et les Technologies and Héma-Québec.

  • ↵2 Address correspondence and reprint requests to Dr. Sonia Néron, Héma-Québec, Recherche et Développement, 2535, boulevard Laurier, Sainte-Foy, Québec, Canada G1V 4M3. E-mail address: sneron{at}hema-quebec.qc.ca

  • ↵3 Abbreviations used in this paper: SAC, S. aureus Cowan strain I protein A insoluble; BrdU, 5-bromo-2′-deoxyuridine, MFI, mean fluorescence intensity; AID, activation-induced cytidine deaminase.

  • Received March 3, 2003.
  • Accepted August 28, 2003.
  • Copyright © 2003 by The American Association of Immunologists

References

  1. ↵
    Klein, U., K. Rajewsky, R. Kuppers. 1998. Human immunoglobulin IgM+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1679.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Black, S. J., W. van der Loo, M. R. Loken, L. A. Herzenberg. 1978. Expression of IgD by murine lymphocytes: loss of surface IgD indicates maturation of memory B cells. J. Exp. Med. 147:984.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Hayakawa, K., R. Ishii, K. Yamasaki, T. Kishimoto, R. R. Hardy. 1987. Isolation of high-affinity memory B cells: phycoerythrin as a probe for antigen-binding cells. Proc. Natl. Acad. Sci. USA 84:1379.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Kuppers, R., U. Klein, M. L. Hansmann, K. Rajewsky. 1999. Cellular origin of human B-cell lymphomas. N. Engl. J. Med. 341:1520.
    OpenUrlCrossRefPubMed
  5. ↵
    Agematsu, K., S. Hokibara, H. Nagumo, A. Komiyama. 2000. CD27: a memory B-cell marker. Immunol. Today 21:204.
    OpenUrlCrossRefPubMed
  6. ↵
    Goodwin, R. G., M. R. Alderson, C. A. Smith, R. J. Armitage, T. VandenBos, R. Jerzy, T. W. Tough, M. A. Schoenborn, T. Davis-Smith, K. Hennen. 1993. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73:447.
    OpenUrlCrossRefPubMed
  7. ↵
    Sugita, K., T. Hirose, D. M. Rothstein, C. Donahue, S. F. Schlossman, C. Morimoto. 1992. CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions. J. Immunol. 149:3208.
    OpenUrlAbstract
  8. ↵
    Tarlinton, D.. 1998. Germinal centers: form and function. Curr. Opin. Immunol. 10:245.
    OpenUrlCrossRefPubMed
  9. ↵
    Neuberger, M. S., M. R. Ehrenstein, C. Rada, J. Sale, F. D. Batista, G. Williams, C. Milstein. 2000. Memory in the B-cell compartment: antibody affinity maturation. Philos. Trans. R. Soc London B Biol. Sci. 355:357.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Lahvis, G. P., J. Cerny. 1997. Induction of germinal center B cell markers in vitro by activated CD4+ T lymphocytes: the role of CD40 ligand, soluble factors, and B cell antigen receptor cross-linking. J. Immunol. 159:1783.
    OpenUrlAbstract
  11. ↵
    Bishop, G. A., B. S. Hostager. 2001. B lymphocyte activation by contact-mediated interactions with T lymphocytes. Curr. Opin. Immunol. 13:278.
    OpenUrlCrossRefPubMed
  12. ↵
    van Kooten, C., J. Banchereau. 2000. CD40-CD40 ligand. J. Leukocyte Biol. 67:2.
    OpenUrlAbstract
  13. ↵
    Grassme, H., J. Bock, J. Kun, E. Gulbins. 2002. Clustering of CD40 ligand is required to form a functional contact with CD40. J. Biol. Chem. 277:30289.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Fuleihan, R. L.. 1998. The X-linked hyperimmunoglobulin M syndrome. Semin. Hematol. 35:321.
    OpenUrlPubMed
  15. ↵
    Foy, T. M., A. Aruffo, J. Bajorath, J. E. Buhlmann, R. J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591.
    OpenUrlCrossRefPubMed
  16. ↵
    Grewal, I. S., R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111.
    OpenUrlCrossRefPubMed
  17. ↵
    van den Eertwegh, A. J., R. J. Noelle, M. Roy, D. M. Shepherd, A. Aruffo, J. A. Ledbetter, W. J. Boersma, E. Claassen. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J. Exp. Med. 178:1555.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Foy, T. M., D. M. Shepherd, F. H. Durie, A. Aruffo, J. A. Ledbetter, R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Kindler, V., R. H. Zubler. 1997. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3. J. Immunol. 159:2085.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Galibert, L., I. Durand, J. Banchereau, F. Rousset. 1994. CD40-activated surface IgD-positive lymphocytes constitute the long term IL-4-dependent proliferating B cell pool. J. Immunol. 152:22.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Nagumo, H., K. Agematsu, K. Shinozaki, S. Hokibara, S. Ito, M. Takamoto, T. Nikaido, K. Yasui, Y. Uehara, A. Yachie, A. Komiyama. 1998. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J. Immunol. 161:6496.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Nagumo, H., K. Agematsu, N. Kobayashi, K. Shinozaki, S. Hokibara, H. Nagase, M. Takamoto, K. Yasui, K. Sugane, A. Komiyama. 2002. The different process of class switching and somatic hypermutation; a novel analysis by CD27− naive B cells. Blood 99:567.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Werner-Favre, C., F. Bovia, P. Schneider, N. Holler, M. Barnet, V. Kindler, J. Tschopp, R. H. Zubler. 2001. IgG subclass switch capacity is low in switched and in IgM-only, but high in IgD+IgM+, post-germinal center (CD27+) human B cells. Eur. J. Immunol. 31:243.
    OpenUrlCrossRefPubMed
  24. ↵
    Banchereau, J., P. de Paoli, A. Valle, E. Garcia, F. Rousset. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Banchereau, J., F. Rousset. 1991. Growing human B lymphocytes in the CD40 system. Nature 353:678.
    OpenUrlCrossRefPubMed
  26. ↵
    Rousset, F., S. Peyrol, E. Garcia, N. Vezzio, M. Andujar, J. A. Grimaud, J. Banchereau. 1995. Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4. Int. Immunol. 7:1243.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Bar-Or, A., E. M. Oliveira, D. E. Anderson, J. I. Krieger, M. Duddy, K. C. O’Connor, D. A. Hafler. 2001. Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state. J. Immunol. 167:5669.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Neron, S., A. Pelletier, M. C. Chevrier, G. Monier, R. Lemieux, A. Darveau. 1996. Induction of LFA-1 independent human B cell proliferation and differentiation by binding of CD40 with its ligand. Immunol. Invest. 25:79.
    OpenUrlCrossRefPubMed
  29. ↵
    Bianchi, A. T. J., G. Koch. 1997. Detection of immunoglobulin-secreting cells. I. Lefkovts, ed. In Immunology Methods Manual: The Comprehensive Sourcebook of Techniques Vol. 2:1036. Academic, London.
    OpenUrl
  30. ↵
    Martin, A., P. D. Bardwell, C. J. Woo, M. Fan, M. J. Shulman, M. D. Scharff. 2002. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415:802.
    OpenUrlCrossRefPubMed
  31. ↵
    Maniatis, T., E. F. Fritsch, J. Sambrook. 1989. Extraction and purification of plasmid DNA. C. Nolan, ed. In Molecular Cloning, a Laboratory Manual Vol. 1:1.21. Cold Spring Harbor Lab. Press, New York.
    OpenUrl
  32. ↵
    Lefranc, M. P., V. Giudicelli, C. Ginestoux, J. Bodmer, W. Muller, R. Bontrop, M. Lemaitre, A. Malik, V. Barbie, D. Chaume. 1999. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 27:209.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Lefranc, M. P.. 2001. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 29:207.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Ruiz, M., V. Giudicelli, C. Ginestoux, P. Stoehr, J. Robinson, J. Bodmer, S. G. Marsh, R. Bontrop, M. Lemaitre, G. Lefranc, D. Chaume, M. P. Lefranc. 2000. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 28:219.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Jung, D., S. Néron, R. Lemieux, A. Roy, M. Richard. 2001. Telomere-independent reduction of human B lymphocyte proliferation during long-term culture. Immunol. Invest. 30:157.
    OpenUrlCrossRefPubMed
  36. ↵
    Tangye, S. G., Y. J. Liu, G. Aversa, J. H. Phillips, J. E. de Vries. 1998. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188:1691.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Jung, J., J. Choe, L. Li, Y. S. Choi. 2000. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur. J. Immunol. 30:2437.
    OpenUrlCrossRefPubMed
  38. ↵
    Honjo, T., K. Kinoshita, M. Muramatsu. 2002. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol. 20:165.
    OpenUrlCrossRefPubMed
  39. ↵
    Galibert, L., J. van Dooren, I. Durand, F. Rousset, R. Jefferis, J. Banchereau, S. Lebecque. 1995. Anti-CD40 plus interleukin-4-activated human naive B cell lines express unmutated immunoglobulin genes with intraclonal heavy chain isotype variability. Eur. J. Immunol. 25:733.
    OpenUrlCrossRefPubMed
  40. ↵
    Huang, S. C., A. M. Glas, G. V. Pinchuk, E. H. Van Montfort, S. P. Rao, R. Jiang, E. C. Milner. 1999. Human B cells accumulate immunoglobulin V gene somatic mutations in a cell contact-dependent manner in cultures supported by activated T cells but not in cultures supported by CD40 ligand. Clin. Exp. Immunol. 116:441.
    OpenUrlCrossRefPubMed
  41. ↵
    Tangye, S. G., D. T. Avery, E. K. Deenick, P. D. Hodgkin. 2003. Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. J. Immunol. 170:686.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Agematsu, K., T. Kobata, F. C. Yang, T. Nakazawa, K. Fukushima, M. Kitahara, T. Mori, K. Sugita, C. Morimoto, A. Komiyama. 1995. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur. J. Immunol. 25:2825.
    OpenUrlCrossRefPubMed
  43. ↵
    Gray, D.. 1993. Immunological memory. Annu. Rev. Immunol. 11:49.
    OpenUrlCrossRefPubMed
  44. ↵
    Vitetta, E. S., M. T. Berton, C. Burger, M. Kepron, W. T. Lee, X. M. Yin. 1991. Memory B and T cells. Annu. Rev. Immunol. 9:193.
    OpenUrlCrossRefPubMed
  45. ↵
    McHeyzer-Williams, M. G.. 1997. Immune response decisions at the single cell level. Semin. Immunol. 9:219.
    OpenUrlCrossRefPubMed
  46. ↵
    Bonhomme, D., L. Hammarstrom, D. Webster, H. Chapel, O. Hermine, F. Le Deist, E. Lepage, P. H. Romeo, Y. Levy. 2000. Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J. Immunol. 165:4725.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    Massinga-Loembé, M., S. Néron, R. Delage, A. Darveau. 2002. Analysis of expressed VH genes in persistent polyclonal B cell lymphocytosis reveals an absence of selection in proliferating CD27+IgM+IgD+ memory B cells. Eur. J. Immunol. 32:3678.
    OpenUrlCrossRefPubMed
  48. ↵
    Jacquot, S., L. Macon-Lemaitre, E. Paris, T. Kobata, Y. Tanaka, C. Morimoto, S. F. Schlossman, F. Tron. 2001. B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. Int. Immunol. 13:871.
    OpenUrlAbstract/FREE Full Text
  49. ↵
    Ling, N. R.. 2000. Immunoglobulin production by cultured human lymphocytes. J. Immunol. Methods 238:3.
    OpenUrlCrossRefPubMed
  50. ↵
    Tangye, S. G., A. Ferguson, D. T. Avery, C. S. Ma, P. D. Hodgkin. 2002. Isotype switching by human B cells is division-associated and regulated by cytokines. J. Immunol. 169:4298.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    Roy, A., E. Krzykwa, R. Lemieux, S. Neron. 2001. Increased efficiency of γ-irradiated versus mitomycin C-treated feeder cells for the expansion of normal human cells in long-term cultures. J. Hematother. Stem Cell Res. 10:873.
    OpenUrlCrossRefPubMed
  52. ↵
    Lee, W. T., X. M. Yin, E. S. Vitetta. 1990. Functional and ontogenetic analysis of murine CD45Rhigh and CD45RlowCD4+ T cells. J. Immunol. 144:3288.
    OpenUrlAbstract
  53. ↵
    Bradley, L. M., M. Croft, S. L. Swain. 1993. T-cell memory: new perspectives. Immunol. Today 14:197.
    OpenUrlCrossRefPubMed
  54. ↵
    Bradley, L. M., D. D. Duncan, K. Yoshimoto, S. L. Swain. 1993. Memory effectors: a potent, IL-4-secreting helper T cell population that develops in vivo after restimulation with antigen. J. Immunol. 150:3119.
    OpenUrlAbstract
  55. ↵
    McHeyzer-Williams, M. G., L. J. McHeyzer-Williams, J. Fanelli Panus, G. Bikah, R. R. Pogue-Caley, D. J. Driver, M. D. Eisenbraun. 2000. Antigen-specific immunity: Th cell-dependent B cell responses. Immunol. Res. 22:223.
    OpenUrlCrossRefPubMed
  56. ↵
    Roy, M., T. Waldschmidt, A. Aruffo, J. A. Ledbetter, R. J. Noelle. 1993. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol. 151:2497.
    OpenUrlAbstract
  57. ↵
    Lee, B. O., L. Haynes, S. M. Eaton, S. L. Swain, T. D. Randall. 2002. The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. J. Exp. Med. 196:693.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology: 171 (9)
The Journal of Immunology
Vol. 171, Issue 9
1 Nov 2003
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
CD40 Stimulation of Human Peripheral B Lymphocytes: Distinct Response from Naive and Memory Cells
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
CD40 Stimulation of Human Peripheral B Lymphocytes: Distinct Response from Naive and Memory Cells
Jessie F. Fecteau, Sonia Néron
The Journal of Immunology November 1, 2003, 171 (9) 4621-4629; DOI: 10.4049/jimmunol.171.9.4621

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
CD40 Stimulation of Human Peripheral B Lymphocytes: Distinct Response from Naive and Memory Cells
Jessie F. Fecteau, Sonia Néron
The Journal of Immunology November 1, 2003, 171 (9) 4621-4629; DOI: 10.4049/jimmunol.171.9.4621
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
  • Regulatory Roles of IL-2 and IL-4 in H4/Inducible Costimulator Expression on Activated CD4+ T Cells During Th Cell Development
  • Induction of CD4+ T Cell Apoptosis as a Consequence of Impaired Cytoskeletal Rearrangement in UVB-Irradiated Dendritic Cells
Show more CELLULAR IMMUNOLOGY AND IMMUNE REGULATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606